GTCardio Takes Improved Cardio-Metabolic Monitoring to J.P. Morgan Conference

​

GTCardio Inc. will present at J.P. Morgan's 42nd Annual Healthcare Conference. We’re honored to join the prestigious panel of presenters to help further healthcare innovation and improve financial performance of our industry, while driving significant change to cardiovascular monitoring. 

 

GTCardio joins the event, on behalf of MIT Angels and McKinsey & Company to present on January 8th from 6 to 9 pm on “AI in Healthcare”. 

 

CEO, Silvia Veronese, will be sharing recent advancements to accelerate the development of non-invasive continuous cardiovascular monitoring with the GTCardio AI-driven platform. In the session you will learn about the importance of real-time analysis of hemodynamics data and how it can seamlessly integrate into healthcare workflows to improve and accelerate decision making. 

​

Interested partners and investors are invited to collect with Silvia at this event which serves as a nexus for the industry; connecting global leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

​

Let’s meet. 

​

Join the “AI in Healthcare” session and schedule a meeting with Silvia by using the “contact us” form on the GTCardio website.

​We look forward to the opportunity to share GTCardio's recent progress in addressing the critical needs of  help minimizing the risk of cardio-metabolic diseases. 

​